Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TC Energy
TRP
|
+$1.7B |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$505M |
| 3 |
Johnson & Johnson
JNJ
|
+$441M |
| 4 |
Mastercard
MA
|
+$406M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$394M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.61B |
| 2 |
NVIDIA
NVDA
|
+$1.42B |
| 3 |
Visa
V
|
+$1.16B |
| 4 |
Apple
AAPL
|
+$907M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$716M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.3% |
| 2 | Financials | 8.57% |
| 3 | Healthcare | 7.58% |
| 4 | Consumer Discretionary | 7.43% |
| 5 | Industrials | 5.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4376
Clover Health Investments
CLOV
$2.45B
| $1.41M | ﹤0.01% |
500,281
-216,048
| -30% | -$495K |
|
4377
Tejon Ranch
TRC
$444M
| $1.41M | ﹤0.01% |
80,187
+22,069
| +38% | +$392K |
|
4378
Backblaze
BLZE
$1.12B
| $1.41M | ﹤0.01% |
220,103
+173,807
| +375% | +$1.08M |
|
4379
Gencor Industries
GENC
$212M
| $1.4M | ﹤0.01% |
67,313
+30,707
| +84% | +$619K |
|
|
LUMO
4380
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $1.4M | ﹤0.01% |
362,198
-44,413
| -11% | -$123K |
|
4381
Mistras Group
MG
$498M
| $1.39M | ﹤0.01% |
122,522
+88,379
| +259% | +$908K |
|
4382
Transportadora de Gas del Sur
TGS
$4.38B
| $1.39M | ﹤0.01% |
75,844
+21,097
| +39% | +$397K |
|
4383
OmniAb
OABI
$325M
| $1.39M | ﹤0.01% |
328,139
+152,035
| +86% | +$657K |
|
4384
Acrivon Therapeutics
ACRV
$72.3M
| $1.39M | ﹤0.01% |
198,168
+173,784
| +713% | +$1.37M |
|
4385
Schwab US Large-Cap Growth ETF
SCHG
$62.1B
| $1.39M | ﹤0.01% |
53,260
-10,212
| -16% | -$257K |
|
4386
FlexShares Morningstar US Market Factors Tilt Index Fund
TILT
$2.24B
| $1.39M | ﹤0.01% |
6,511
| – | – |
|
4387
WisdomTree US MidCap Dividend Fund
DON
$4.07B
| $1.38M | ﹤0.01% |
27,086
+8,110
| +43% | +$396K |
|
4388
Capital Bancorp
CBNK
$616M
| $1.38M | ﹤0.01% |
53,859
+19,085
| +55% | +$460K |
|
4389
PUT
Acadia Pharmaceuticals
ACAD
$4.9B
| $1.38M | ﹤0.01% |
89,900
| – | – |
|
|
4390
CALL
Acadia Pharmaceuticals
ACAD
$4.9B
| $1.38M | ﹤0.01% |
89,800
| – | – |
|
4391
First Trust Nasdaq Pharmaceuticals ETF
FTXH
$922M
| $1.38M | ﹤0.01% |
47,842
-18,655
| -28% | -$534K |
|
4392
SRH US Quality ETF
SRHQ
$217M
| $1.38M | ﹤0.01% |
36,690
-348
| -0.9% | -$12.3K |
|
|
JPUS
4393
JPMorgan Diversified Return US Equity ETF
JPUS
$462M
| $1.38M | ﹤0.01% |
11,514
| – | – |
|
4394
CALL
Apollo Global Management
APO
$73.7B
| $1.37M | ﹤0.01% |
11,000
-184,000
| -94% | -$21.2M |
|
4395
Riskified
RSKD
$694M
| $1.37M | ﹤0.01% |
290,451
-3,460
| -1% | -$18.9K |
|
4396
Caribou Biosciences
CRBU
$163M
| $1.37M | ﹤0.01% |
700,892
-487,872
| -41% | -$999K |
|
4397
iShares US Telecommunications ETF
IYZ
$1.25B
| $1.37M | ﹤0.01% |
54,384
-100,000
| -65% | -$2.3M |
|
4398
Digimarc Corp
DMRC
$171M
| $1.37M | ﹤0.01% |
50,949
-5,017
| -9% | -$148K |
|
4399
Schwab Fundamental US Small Company Index ETF
FNDA
$9.27B
| $1.37M | ﹤0.01% |
+45,952
| New | +$1.32M |
|
4400
iShares CMBS ETF
CMBS
$474M
| $1.37M | ﹤0.01% |
+27,921
| New | +$1.34M |
|
Similar funds
Goldman Sachs's Q3 2024 Portfolio in Review
As of Q3 2024, Goldman Sachs held 6,216 positions worth $621B, up 5% from $591B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Goldman Sachs's Q3 2024 filing shows 596 new, 2,752 increased, 1,995 reduced and 427 closed positions. Its largest new stake was Smurfit Westrock: 3,644,566 shares worth $180M. The largest sale was Tesla, an estimated $1.61B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.
- Goldman Sachs's largest Q3 2024 buy was Smurfit Westrock: 3,644,566 shares worth $180M.
- Goldman Sachs added most to TC Energy in Q3 2024, an estimated $1.7B increase.
- Goldman Sachs's biggest Q3 2024 reduction was Tesla, cutting an estimated $1.61B.
- Goldman Sachs fully exited WestRock Company in Q3 2024, selling an estimated $204M.
- Goldman Sachs's ten largest holdings make up 19% of its $621B portfolio in Q3 2024.
- Goldman Sachs opened 596 new positions and closed 427 in Q3 2024.
- Goldman Sachs's portfolio value rose 5% quarter-over-quarter to $621B.
Based on Goldman Sachs's 13F filing for Q3 2024, filed 14 Nov 2024.